Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Communication × Dermatologic × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 15 Gastrointestinal 12 Thoracic 8 Genitourinary 8 Other hematologic neoplasm 3 Lymphoid 3 Head & Neck 2 CNS 2 Plasma cell 1 Other 1 Gynecologic 1 Endocrine 1 Dermatologic 1

Conditions

Melanoma 1394 Skin Neoplasms 305 Lymphoma, T-Cell, Cutaneous 277 Carcinoma, Basal Cell 194 Mycosis Fungoides 191 Sezary Syndrome 174 Breast Neoplasms 166 Lymphoma, Non-Hodgkin 162 Leukemia, Lymphocytic, Chronic, B-Cell 160 Lymphoma, Follicular 155 Precursor Cell Lymphoblastic Leukemia-Lymphoma 152 Lymphoma, Large B-Cell, Diffuse 152 Lymphoma, Mantle-Cell 150 Lymphoma, B-Cell, Marginal Zone 150 Lymphoma 149 Burkitt Lymphoma 144 Uveal Melanoma 143 Hodgkin Disease 143 Lymphoma, Large-Cell, Immunoblastic 142 Multiple Myeloma 132 Keratosis, Actinic 130 Neoplasms 115 Leukemia, Myeloid, Acute 111 Neoplasm Metastasis 107 Lung Neoplasms 102 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 100 Lymphoma, Large-Cell, Anaplastic 98 Leukemia, Myeloid, Chronic-Phase 93 Leukemia, Myeloid, Accelerated Phase 93 Leukemia 92

Interventions

Surveys and Questionnaires 1 Interviews as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06073548 2023-10-10

SALOME Quali

Institut Curie

Not yet recruiting

Uveal Melanoma, Communication

Data powered by HemOnc (CC BY 4.0) Colophon ⚡